Our Medicine Export Portfolio
Verve Biosciences is a pharmaceutical consulting firm dedicated to helping patients gain access to vaccines and specialty medicines from across the globe. Our portfolio includes over 450 primary care products, distributed in 92 countries worldwide.
Verve Bioscience supports the international supply and export of oncology medicines from India through an established network of qualified pharmaceutical manufacturing partners. The company works with manufacturers that may hold recognized quality certifications and approvals, including WHO-GMP, EU-GMP, US FDA, and PIC/S, where applicable to specific products and facilities.
Verve Bioscience facilitates access to a broad range of oncology products, including
- chemotherapy agents,
- targeted therapies, and
- immunotherapy medicines,
- supportive cancer care medicines
subject to regulatory requirements, product availability, and market-specific approvals.
To support international trade processes, Verve Bioscience assists with the preparation and coordination of export documentation required by importing authorities and customers. The company also collaborates with logistics partners to arrange appropriate transportation solutions, including temperature-controlled handling for products that require cold chain management. Through structured supply planning and coordination, Verve Bioscience aims to support the procurement needs of hospitals, wholesalers, distributors, and other authorized healthcare stakeholders across both regulated and emerging markets. All activities are conducted in accordance with applicable laws, regulations, and product registration requirements in the destination country.
Global Bulk Export Solutions for Oncology Medicines
We specialize in bulk oncology medicine export from India, supporting large-scale procurement requirements for hospitals, distributors, and healthcare institutions across global markets. In oncology supply, consistency is critical—treatment cycles depend on uninterrupted availability, precise handling, and timely delivery. Our export capabilities are designed to meet these demands with a strong focus on scalability, compliance, and supply reliability.
Our Capabilities Include:
- High-volume order fulfillment aligned with hospital and distributor demand
- Flexible packaging options, including hospital packs and bulk formats
- Private labeling and contract manufacturing support for global partners
- Continuous supply planning for long-term procurement contracts
- Emergency supply support for urgent and critical oncology requirements
- Coordinated logistics for time-sensitive and temperature-controlled shipments
Our infrastructure and global sourcing network ensure every shipment meets international standards, delivering reliability, consistency, and compliance in every oncology export.
Mr. Rakesh Khanna.
Healthcare Consultant
Rakesh started my international journey from South East Asia as Country Head for Malaysia & Singapore representing one of India’s leading pharmaceutical company.
After completing my job successfully there, I moved to Ho Chi Minh City as Group Country Head in charge of four countries. We had our own team with 40+ field force managing operations in two of the countries and the other two countries were managed on distributor model.
Most of these countries were dominated by US and European MNCs but I with the team was able to create a perfect niche for ourselves with good business in few of the major therapy areas.
Contact a Trusted Medicine Exporter from India:
Looking for a reliable partner for oncology medicine export from India?
We support global importers, wholesalers, suppliers, hospitals, distributors, NGOs, and healthcare providers worldwide.
Email: info@cancermedicinesnetwork.com
WhatsApp: +91 98104 69557
Request pricing and availability within 24 hours.
Our Global Network
Verve Biosciences has shipped Specialty Medicines in Burma, Cambodia, Hong Kong, Indonesia, Japan, Laos, Malaysia, Papua New Guinea, Philippines, South Korea, Singapore, Thailand, Taiwan, Vietnam, Israel, Kuwait, Qatar, Saudi Arabia, United Arab Emirates, Dubai, Abu Dhabi, Bulgaria, Croatia, Cyprus, Czech Republic, Finland, France, Corsica, Georgia, Germany, Greece, Hungary, Ireland, Italy, Luxembourg, Montenegro, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Sweden, Switzerland, Ukraine, United Kingdom, England, Scotland, Wales.